Allergy & Asthma Network (AAN) and the Asthma and Allergy Foundation of America (AAFA) today announced the launch of Be the Boss of Your Asthma, a national educational program that aims to raise awareness of severe eosinophilic asthma – or S.E.A. – a serious and often hard-to-control form of asthma.
For Andrew, breathing is a daily, ongoing struggle. Andrew was first diagnosed with moderate asthma when he was 10 years old. His first trip to the emergency room due to an asthma attack would be the first of many all-too-familiar trips. Through high school, asthma didn’t just affect him physically, but emotionally and academically, too. In addition to working hard to keep up with classwork from missed days, he also had to face relentless bullying – so severe that he had to change schools to...
Michelle lost her sister, Tiffany, when she died from asthma in 2014. Tragically, Tiffany had suffered her first-ever exercise-induced asthma attack. After the devastating loss of her sister, Michelle and her family wanted to make sure that no other family had to lose a loved one like their family did. Michelle and her family now raise awareness about asthma and support AAFA because of AAFA’s mission to improve the lives of people with asthma and allergic diseases through education, advocacy...
Tiffany Phu loved sports and spent most of her time outdoors. So it was fitting that on a balmy May night, her older sister Michelle confidently threw out the first pitch at a Philadelphia Phillies game. Michelle advocates for asthma awareness in memory of her sister Tiffany. “Tiffany enjoyed playing all types of sports,” notes Michelle. Tiffany died from asthma two years earlier, in May 2014, after running track at her Texas school. The eighth grader was just 13. The sudden and tragic loss...
Does your asthma or your child’s asthma always seem to get worse in September? If so, you’re not alone. In fact, researchers have studied this issue. Here is what they found. September is a difficult time for those with asthma There is a September asthma hospitalization “epidemic.” Many more people are hospitalized for asthma shortly after school starts than at any other time of the year. The number of asthma hospitalizations peak first for school-age children, then preschool children, then...
The Asthma and Allergy Foundation of America is sharing this press release from the National Institute of Allergy and Infectious Diseases to bring you the latest research news quickly. NIAID-Sponsored Study Finds Factors that Influence Asthma Severity in Inner-City Children Results Shed Light on Complexities of Asthma in Children [PRESS RELEASE] October 5, 2016 - In a novel study of 717 children between ages 6 and 17, researchers have identified major factors associated with asthma severity...
When you have asthma, you may have different health care providers who help you manage your asthma. These may include a primary care doctor, specialists and other experts who oversee parts of your treatment plan. Since proper asthma management is key, you need to understand each one’s focus and the role they play in your care. This is the first step toward building a partnership with your health care team for the best quality of life possible.
Many consider personalized medicine the future of health care, and for good reason. As we learn about patients, genetics and diseases, we see that a standard approach is not the best. The purpose of personalized medicine is to provide custom treatment plans for patients. While customized care can help patients, it also adds challenges due to many factors that influence asthma.
Severe ASTHMA (Asthma Symptoms, Treatment, Health Management and Activities™) Care for Adults is a FREE self-paced course that helps adults and their caregivers learn how to manage severe asthma. It explains severe and uncontrolled asthma, the impact of severe asthma, asthma management plans and severe asthma treatments.
Air conditioners for people with asthma, healthy groceries, rides to medical appointments and home-delivered meals may be among the new benefits added to Medicare Advantage coverage when new federal rules take effect next ye
The FDA has approved another biologic treatment, Dupixent, for the treatment of both moderate and severe asthma patients with eosinophilic phenotype
and oral corticosteroid-dependent asthma, regardless of phenotype.
FDA's most prominent warning, the Boxed Warning, about asthma-related death has been removed from the drug labels of medicines that contain both an ICS and LABA. A FDA review of four large clinical safety trials shows that treating asthma with long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS) does not result in significantly more serious asthma-related side effects than treatment with ICS alone.
By Megan Roberts, Community Engagement Program Manager at the Asthma and Allergy Foundation of America I have had exercise-induced bronchoconstriction (asthma) for as long as I can remember. I have also been very active most of my life. Until the end of 2016, one didn’t really affect the other. Pretreating with albuterol before exercise managed all my asthma symptoms. In recent years, as my exercise habits have increased, I haven’t even carried an inhaler at times. At the end of 2011, I...
AstraZeneca announced that the US Food and Drug Administration (FDA) approved SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol 80/4.5 micrograms for the treatment of asthma in pediatric patients aged six up to 12 years.
[Press Release] Teva Announces FDA Approval of Two New RespiClick® Maintenance Inhalers for the Treatment of Asthma Approvals Expand Portfolio of Respiratory Medicines Delivered in RespiClick® Inhaler Designed to Eliminate the Need for Hand-Breath Coordination During Inhalation JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced that the U.S. Food and Drug Administration (FDA) approved two products for adolescent and adult patients with asthma.
About 25 million Americans have asthma. There is no cure. But you can manage it with a proper treatment plan and by avoiding triggers. But there might be one thing out of your control that can make managing asthma a challenge: where you live. Today, the Asthma and Allergy Foundation of America (AAFA) has released the 2018 Asthma Capitals™ report. This report ranks the top 100 cities in the U.S. where it’s challenging to live with asthma.
Asthma affects over 6 million American children and nearly 18 million adults. Among children, asthma is the third leading cause of hospitalizations and one of the top causes of school absences. Adults miss more than 14 million days of work each year. But still, many don't understand what it is like to manage a chronic illness like asthma. Share awareness images and messages this month to help others understand. Find these images, and more, in our Shareable Awareness Images photo album. Use...
A new over-the-counter device that works with your smartphone will warn you if your asthma is about to flare. The FDA recently approved the device, called Wing. Wing attaches to your smartphone and measures your lung function. Wing has a sensor that monitors your asthma zones. The pocket-sized device includes a mouthpiece. The Wing app collects and analyzes the data from the lung test.
Lynnnowik, the device is not out yet -- the Wing website (click the blue letters to take you to their website) has some information about it and a place to sign up for news alerts. The blog says that they're hoping to release it in the fall. In the meantime, how can we help you with your asthma? I hope you'll join us on our Daily Roll Call "thread" on the forums -- it's a great way to get to know other folks who are managing asthma and get a little encouragement each day!
AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.
QVAR® RediHaler™ (beclomethasone dipropionate HFA) Inhalation Aerosol will become available by prescription on February 12, 2018. QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol will no longer be available to patients.
I like the awareness brought to people with SEA, and the checklist for doctors visits at the site! I have an eosinophil- related condition and asthma is one component of it (and the most difficult to deal with). My main trigger is pet dander (which I fervently avoid) but it is very hard when service dogs are allowed in the allergists office waiting room. I also take all the medications recommended, and still it is difficult. I am making progress though.
We are proud to announce that the Asthma and Allergy Foundation of America’s blog has again been named one of the best asthma blogs by Healthline in 2018! Healthline is a health site with information on many health topics.
Asthma is a complex condition. People can have different levels of asthma, triggers and treatments. Whether you’ve just been diagnosed or have had asthma for some time, you may need help making sense of it all.
The Asthma and Allergy Foundation of America (AAFA) has created the ASTHMA Care for Adults program. This program covers a full range of topics someone with asthma needs to know.
Asthma is a chronic lung disease where the airways are inflamed. For many people, asthma can be controlled with medicines and avoiding triggers. But severe asthma is not that simple. How do you know if you have severe asthma?
For many, asthma is caused by an allergic reaction to something. This is called allergic asthma is the most common. But a small number of people with asthma have “non-allergic asthma.” Lynn Johnson is part of this group. Lynn developed non-allergic asthma seven years ago, as an adult.
During gym class, young April Behounek, noticed a burning sensation in her chest and trouble breathing. She told her mom and they went to see an allergist in northern Wisconsin. At age 10, April was diagnosed with asthma and an allergy to dogs. She grew up managing her asthma with the support of her parents and her doctors. This included using both long-term control and quick-relief inhalers.
Shari Duncan has had asthma for more than three decades. In recent years it has become quite severe. Shari takes daily asthma maintenance medicines, does nebulizer breathing treatments and works hard to avoid her biggest asthma triggers. She also uses her quick-relief inhaler about once or twice a week. In spite of these efforts, four to six times a year Shari is hospitalized for asthma.
AstraZeneca and its partner Amgen Inc. (Amgen) announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma, without an eosinophilic phenotype, who are receiving inhaled corticosteroids/long-acting beta2-agonists with or without oral corticosteroids and additional asthma controllers.
Every September, asthma hospitalizations rise. Doctors see more people with asthma episodes and attacks. The third week of the month is the worst. It is called the September Asthma Epidemic or Asthma Peak Week. Everyone with asthma needs to be prepared.
I use the QVAR respihaler too and for me, not having propellant in it made a huge difference. My lungs have never liked the prolellant but I've always managed because the steroid component took care of the issues I had but the new respihaler is MUCH better for me.
There is no cure for asthma or allergies, which is why research is so important. AAFA supports research that will lead to better care, more effective treatments and, one day, a cure. Since May is Asthma and Allergy Awareness Month, it’s the perfect time to spotlight health research and how it can help those with asthma and allergies. On Friday, May 13, AAFA is co-sponsoring a Congressional briefing , From Discovery to Delivery: Research at Work Against Allergies and Asthma . The briefing...
The Asthma and Allergy Foundation of America (AAFA) believes your voice is valuable part of asthma research. And we want to empower people with asthma, caregivers and health care providers to take an active role in research.
Promoting Asthma Patient Engagement in Research (PAPER) is a new research project from AAFA and the Patient-Centered Outcomes Research Institute (PCORI). Through this project, you can influence research that improves asthma understanding and treatment.
When you block a person, they can no longer invite you to a private message or post to your profile wall. Replies and comments they make will be collapsed/hidden by default. Finally, you'll never receive email notifications about content they create or likes they designate for your content.
Note: if you proceed, you will no longer be following .